Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation

被引:4
|
作者
Rubio-Langre, Sonia [1 ]
Aguilar-Sola, Soledad [2 ]
Matias Lorenzutti, Augusto [2 ]
San Andres, Manuel I. [1 ]
De Lucas, Jose J. [1 ]
Litterio, Nicolas J. [2 ]
机构
[1] Univ Complutense Madrid, Fac Vet, Dept Toxicol & Farmacol, Madrid, Spain
[2] Univ Catolica Cordoba, Fac Ciencias Agr, IRNASUS CONICET, Av Armada Argentina 3555 X5016DHK, Cordoba, Argentina
关键词
Llamas; Marbofloxacin; Monte Carlo simulation; pharmacodynamics; pharmacokinetics; PRUDENT USE; RESISTANCE; BACTERIA; DOSAGE; SUSCEPTIBILITY; ENROFLOXACIN; DISPOSITION; EMERGENCE;
D O I
10.1111/jvp.12698
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In llama crias (tekes), Escherichia coli and Staphylococcus aureus are major pathogens, and marbofloxacin could be a suitable choice. The objectives of this study were (a) to evaluate the serum pharmacokinetics of marbofloxacin (5 mg/kg) after intravenous administration in tekes and simulate a multidose regimen; (b) to emulate pharmacokinetic profiles after single dose and steady-state conditions by Monte Carlo simulation (c) to determine the MIC of regional strains of Escherichia coli and Staphylococcus aureus; (d) to perform a PK/PD analysis by Monte Carlo simulation. Pharmacokinetics of marbofloxacin was evaluated in six animals at 3, 10, 24, 50, and 80 days after birth. Marbofloxacin were determined by HPLC. A steady-state multi-dose simulation was carried out, and concentration-time profiles were generated by Monte Carlo simulation. MIC of marbofloxacin against regional E. coli and S. aureus strains were also determined. Finally, a PK/PD analysis was conducted by Monte Carlo simulation. After pharmacokinetic analysis, clearance showed a trend to increase (0.14 and 0.18 L kg(-1) hr(-1)), and AUC (36.74 and 15.21 mu g hr(-1) ml(-1)) and Vss (3.06 and 3.37 L/kg) trended to decrease at 3 and 80 days-old, respectively, showing accumulation similar to 50% in animals with 3 days. All strains tested of E. coli (MIC90 = 0.06 mu g/ml) and S. aureus (MIC90 = 0.25 mu g/ml) were susceptible to marbofloxacin. PK/PD analysis suggests that the therapeutic regimen of marbofloxacin could be effective for infections caused by E. coli strains in animals between 3 and 80 days, with a CFR for C-max/MIC > 10 of 100% and for AUC(24)/MIC > 125 of 99.99%; and for infections produced by S. aureus in animals between 3 and 24 days old, with a CFR for C-max/MIC > 10 of 93.08% and for AUC(24)/MIC > 60 of 97.01%, but a higher dose should be used in older animals, because PK/PD endpoints were not met.
引用
收藏
页码:861 / 870
页数:10
相关论文
共 50 条
  • [1] Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats
    Dova, Samanta Waxman
    Andres, M. Dolores San
    Gonzalez, Fernando
    Andres, Manuel I. San
    De Lucas, Jose J.
    Rodriguez, Casilda
    [J]. VETERINARY JOURNAL, 2007, 174 (02): : 425 - 427
  • [2] Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats
    Bhardwaj, Pallavi
    Sidhu, Pritam K.
    Lonare, M. K.
    Kaur, Rajdeep
    Dumka, V. K.
    Rampal, S.
    [J]. RESEARCH IN VETERINARY SCIENCE, 2018, 121 : 111 - 115
  • [3] Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin after intravenous and intramuscular administration in beagle dogs
    Yohannes, Sileshi
    Awji, Elias Gebru
    Lee, Seung-Jin
    Park, Seung-Chun
    [J]. XENOBIOTICA, 2015, 45 (03) : 264 - 269
  • [4] Pharmacokinetic/pharmacodynamic integration of marbofloxacin after oral and intravenous administration in rainbow trout (Oncorhynchus mykiss)
    Corum, Orhan
    Terzi, Ertugrul
    Corum, Duygu Durna
    Kenanoglu, Osman Nezih
    Bilen, Soner
    Uney, Kamil
    [J]. AQUACULTURE, 2020, 514
  • [5] Pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation of cefquinome in llamas, following intravenous, intramuscular and subcutaneous administration in serum and tissue cage fluid
    Alejandro Himelfarb, Martin
    Matias Lorenzutti, Augusto
    Javier Litterio, Nicolas
    del Pilar Zarazaga, Maria
    Soledad Aguilar-Sola, Maria
    Julio De Lucas, Jose
    Ignacio San Andres, Manuel
    Rubio-Langre, Sonia
    [J]. SMALL RUMINANT RESEARCH, 2017, 149 : 134 - 140
  • [6] Pharmacokinetic/Pharmacodynamic Evaluation of Marbofloxacin for Common Pathogens in Swine Following Single Intramuscular Administration of Different Doses
    Rambaldi, Julie
    Barbarossa, Andrea
    Morbidelli, Eva
    Zaghini, Anna
    [J]. PAKISTAN VETERINARY JOURNAL, 2018, 38 (02) : 222 - 224
  • [7] Pharmacokinetic and pharmacodynamic evaluation of triamcinolone acetonide after intravenous, oral, and inhaled administration
    Rohatagi, S
    Hochhaus, G
    Mollmann, H
    Barth, J
    Galia, E
    Erdmann, M
    Sourgens, H
    Derendorf, H
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (12): : 1187 - 1193
  • [8] Pharmacokinetic and pharmacodynamic analysis of cefoperazone/sulbactam for the treatment of pediatric sepsis by Monte Carlo simulation
    Ye, Linhu
    Cheng, Lei
    Kong, Lingti
    Zhao, Xinqian
    Xie, Guoyan
    He, Jing
    Liu, Hong
    Deng, Yan
    Wu, Xinyu
    Wang, Tingting
    Yang, Xixiao
    [J]. ANALYTICAL METHODS, 2022, 14 (11) : 1148 - 1154
  • [9] Evaluating the efficacy of different antibiotics against Neisseria gonorrhoeae: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation
    Zhong, Jiaojiao
    Le, Wenjing
    Li, Xuechun
    Su, Xiaohong
    [J]. BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [10] Evaluating the efficacy of different antibiotics against Neisseria gonorrhoeae: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation
    Jiaojiao Zhong
    Wenjing Le
    Xuechun Li
    Xiaohong Su
    [J]. BMC Infectious Diseases, 24